Carrera Capital Advisors increased its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 23.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 39,170 shares of the company's stock after buying an additional 7,353 shares during the quarter. Colgate-Palmolive accounts for about 1.0% of Carrera Capital Advisors' investment portfolio, making the stock its 18th largest position. Carrera Capital Advisors' holdings in Colgate-Palmolive were worth $4,066,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also modified their holdings of the company. Main Street Research LLC raised its position in Colgate-Palmolive by 1.5% in the 2nd quarter. Main Street Research LLC now owns 6,939 shares of the company's stock valued at $673,000 after purchasing an additional 100 shares during the last quarter. Advisor OS LLC increased its stake in shares of Colgate-Palmolive by 4.5% in the 2nd quarter. Advisor OS LLC now owns 2,348 shares of the company's stock valued at $228,000 after buying an additional 101 shares during the period. BLB&B Advisors LLC increased its stake in shares of Colgate-Palmolive by 2.5% in the 2nd quarter. BLB&B Advisors LLC now owns 4,337 shares of the company's stock valued at $421,000 after buying an additional 104 shares during the period. ZWJ Investment Counsel Inc. increased its stake in shares of Colgate-Palmolive by 3.1% in the 2nd quarter. ZWJ Investment Counsel Inc. now owns 3,591 shares of the company's stock valued at $349,000 after buying an additional 109 shares during the period. Finally, Hexagon Capital Partners LLC increased its stake in shares of Colgate-Palmolive by 9.5% in the 2nd quarter. Hexagon Capital Partners LLC now owns 1,274 shares of the company's stock valued at $124,000 after buying an additional 110 shares during the period. Institutional investors own 80.41% of the company's stock.
Analyst Upgrades and Downgrades
CL has been the subject of several research reports. Hsbc Global Res cut Colgate-Palmolive from a "strong-buy" rating to a "hold" rating in a research note on Friday, July 26th. Redburn Atlantic raised Colgate-Palmolive to a "hold" rating in a research note on Thursday, August 1st. Deutsche Bank Aktiengesellschaft cut Colgate-Palmolive from a "buy" rating to a "hold" rating and lifted their price objective for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. Wells Fargo & Company decreased their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an "underweight" rating for the company in a research note on Monday, October 28th. Finally, StockNews.com raised Colgate-Palmolive from a "hold" rating to a "buy" rating in a research note on Wednesday, November 6th. One analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $105.11.
Read Our Latest Stock Report on CL
Insider Buying and Selling
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business's stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company's stock, valued at $3,456,283.86. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, Director Martina Hundmejean sold 2,313 shares of the company's stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now owns 11,755 shares of the company's stock, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Stanley J. Sutula III sold 45,410 shares of the company's stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by corporate insiders.
Colgate-Palmolive Stock Down 0.5 %
Shares of Colgate-Palmolive stock traded down $0.45 during trading on Tuesday, reaching $91.51. The stock had a trading volume of 4,927,123 shares, compared to its average volume of 4,377,176. The company has a market capitalization of $74.76 billion, a price-to-earnings ratio of 26.36, a P/E/G ratio of 3.31 and a beta of 0.42. The stock has a fifty day moving average price of $100.62 and a two-hundred day moving average price of $98.52. Colgate-Palmolive has a 52 week low of $75.17 and a 52 week high of $109.30. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46.
Colgate-Palmolive Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 2.19%. Colgate-Palmolive's payout ratio is presently 57.31%.
About Colgate-Palmolive
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.